Correlation Between Gracell Biotechnologies and Erasca
Can any of the company-specific risk be diversified away by investing in both Gracell Biotechnologies and Erasca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gracell Biotechnologies and Erasca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gracell Biotechnologies and Erasca Inc, you can compare the effects of market volatilities on Gracell Biotechnologies and Erasca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gracell Biotechnologies with a short position of Erasca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gracell Biotechnologies and Erasca.
Diversification Opportunities for Gracell Biotechnologies and Erasca
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Gracell and Erasca is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Gracell Biotechnologies and Erasca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erasca Inc and Gracell Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gracell Biotechnologies are associated (or correlated) with Erasca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erasca Inc has no effect on the direction of Gracell Biotechnologies i.e., Gracell Biotechnologies and Erasca go up and down completely randomly.
Pair Corralation between Gracell Biotechnologies and Erasca
If you would invest (100.00) in Gracell Biotechnologies on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Gracell Biotechnologies or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Gracell Biotechnologies vs. Erasca Inc
Performance |
Timeline |
Gracell Biotechnologies |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Erasca Inc |
Gracell Biotechnologies and Erasca Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Gracell Biotechnologies and Erasca
The main advantage of trading using opposite Gracell Biotechnologies and Erasca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gracell Biotechnologies position performs unexpectedly, Erasca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erasca will offset losses from the drop in Erasca's long position.Gracell Biotechnologies vs. Monte Rosa Therapeutics | Gracell Biotechnologies vs. Design Therapeutics | Gracell Biotechnologies vs. Erasca Inc | Gracell Biotechnologies vs. NextCure |
Erasca vs. Century Therapeutics | Erasca vs. Keros Therapeutics | Erasca vs. Monte Rosa Therapeutics | Erasca vs. Design Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |